The KIRIA Compass is a market intelligence report on a health system, IDN, payer, or practice network, built around your portfolio. Here’s what’s in one, how it’s built, and why 82% physician employment changed what commercial teams need to know.

Hospital and health system purchasing runs through GPOs, value analysis committees, physicians, and finance sign-off. Here’s how each stage works, and who to engage.

How Banner Health is organized, where value-based care fits, and why commercial teams should understand this integrated delivery network.

In the ever-evolving healthcare landscape, Integrated Delivery Networks (IDNs) continue redefining the dynamics of healthcare delivery and decision-making. For a pharmaceutical company, this shift presents both a challenge and an opportunity. The challenge lies in adapting to a model where decisions are increasingly centralized, and the opportunity is in forming strategic partnerships that can lead to mutual growth and enhanced patient care.

For pharmaceutical companies, tapping into the Integrated Delivery Network (IDN) model is key to expanding market share. Remarkably, IDNs influence about 75% of healthcare decisions in the U.S., including crucial drug prescriptions ^1.